Equities

Molina Healthcare Inc

Molina Healthcare Inc

Actions
Health CareHealth Care Equipment & Services
  • Price (USD)212.55
  • Today's Change1.43 / 0.68%
  • Shares traded178.08k
  • 1 Year change76.45%
  • Beta0.7799
Data delayed at least 15 minutes, as of Oct 24 2020 00:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Molina Healthcare, Inc. offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through two segments: Health Plans and Other, which includes its Pathways Health and Community Support LLC (Pathways) business. It arranges healthcare services for persons served by Medicaid, Medicare, the Children's Health Insurance Program (CHIP) and the Marketplace, and products to assist government agencies in their administration of the Medicaid program. The Company's Health Plans segment consists of health plans in approximately 14 states and the Commonwealth of Puerto Rico, and its direct delivery business. Through Molina Healthcare of Kentucky, Inc., it provides Medicaid managed care benefits to Medicaid members in Kentucky.

  • Revenue in USD (TTM)17.68bn
  • Net income in USD797.00m
  • Incorporated2002
  • Employees10.00k
  • Location
    Molina Healthcare Inc200 Oceangate Ste 100LONG BEACH 90802-4317United StatesUSA
  • Phone+1 (562) 435-3666
  • Fax+1 (302) 636-5454
  • Websitehttp://www.molinahealthcare.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MOH:NYQ since
announced
Transaction
value
Affinity Health Plan IncAnnounced29 Sep 202029 Sep 2020Announced30.34%380.00m
Magellan Complete Care Of Virginia LLCAnnounced30 Apr 202030 Apr 2020Announced29.01%850.00m
NextLevel Health Partners IncAnnounced06 Jan 202006 Jan 2020Announced60.37%50.00m
Data delayed at least 15 minutes, as of Oct 24 2020 00:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Irhythm Technologies Inc228.19m-65.10m6.35bn997.00--51.08--27.84-2.46-2.468.624.310.943915.268.77228,876.60-26.93-30.28-32.50-36.6174.0472.37-28.53-31.792.99-42.010.2286--45.6858.06-8.32--106.94--
Encompass Health Corp4.60bn284.80m6.70bn31.57k23.484.5811.181.462.872.8746.2514.710.7474--8.77145,774.505.967.247.468.9996.0496.197.978.91--3.590.657733.987.6614.1723.3211.4916.557.12
LHC Group, Inc.2.06bn118.59m6.85bn15.17k57.224.5741.223.333.793.7965.8747.470.9392--6.90135,794.706.666.268.677.5636.6037.097.094.90--16.250.01860.0014.9323.1850.5734.39-16.35--
Chemed Corporation2.02bn262.52m7.78bn16.64k30.7010.3124.683.8515.9215.92122.4647.391.69199.8815.05121,443.1022.0115.6528.4919.6131.7430.6212.998.630.570981.670.0011.968.755.897.0017.234.008.10
Amedisys Inc1.97bn128.26m8.15bn21.30k64.9311.3053.814.133.873.8759.4722.221.38--8.0792,584.659.088.5712.3711.6940.9141.166.574.28--17.000.35840.0017.6310.186.2757.73-8.06--
Universal Health Services, Inc.11.28bn734.28m9.82bn67.70k13.631.737.860.87068.488.48129.8366.960.9437--7.42166,589.706.277.387.528.67----6.657.510.94257.580.37995.615.636.765.208.3210.1314.87
Davita Inc11.52bn823.57m11.48bn65.00k14.495.166.880.99586.296.3486.5517.660.587481.676.09177,290.405.314.477.885.8031.0029.499.047.131.335.540.73270.00-0.1436-2.3014.45-0.4923.63--
Molina Healthcare, Inc.17.68bn797.00m12.60bn10.00k16.336.2814.320.712813.0213.02287.3133.832.43--12.551,768,400.0010.943.3521.478.2318.6715.244.511.35--13.840.50560.00-10.9111.734.2463.76-13.09--
Oak Street Health, Inc.728.91m-156.35m12.66bn2.30k------17.37-0.7128-0.71283.320.633-----------------1.01---16.68-----13.070.3637--75.07---15.65------
Livongo Health Inc258.00m-33.21m14.11bn785.00--23.89--54.70-0.361-0.3612.755.820.42073.995.47419,507.30-5.41---5.82--75.69---12.87--19.51-30.630.4068--148.71---65.05------
Quest Diagnostics Inc-100.00bn-100.00bn17.07bn47.00k--2.68----------47.41----------6.90--7.97--36.96--9.701.32--0.41234.052.590.770816.138.755.3710.45
Data as of Oct 24 2020. Currency figures normalised to Molina Healthcare Inc's reporting currency: US Dollar USD

Institutional shareholders

55.53%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 30 Jun 20205.79m9.76%
The Vanguard Group, Inc.as of 30 Jun 20205.41m9.12%
BlackRock Fund Advisorsas of 30 Jun 20204.93m8.31%
Renaissance Technologies LLCas of 30 Jun 20203.68m6.20%
Wellington Management Co. LLPas of 30 Jun 20203.20m5.40%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 20203.16m5.33%
Fidelity Management & Research Co. LLCas of 30 Jun 20202.18m3.68%
SSgA Funds Management, Inc.as of 30 Jun 20201.90m3.20%
JPMorgan Securities LLC (Investment Management)as of 30 Jun 20201.67m2.81%
Viking Global Investors LPas of 30 Jun 20201.01m1.71%
More ▼
Data from 30 Jun 2020 - 30 Jun 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.